GlassScriptPhysician profile
Derek S Maroun
NPI 1013218254
$2,969.07
in general payments reported to CMS, 2019-2025
12 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $170 · 2021: $309 · 2022: $821 · 2023: $753 · 2024: $283 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,420.68 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $327.43 | 2019-2025 | Dailies Total1 |
| Horizon Therapeutics Plc | $239.61 | 2022-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $211.49 | 2022 | |
| Coopervision INC. | $174.30 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.72 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $116.86 | 2023 | Tecnis Iol |
| Mallinckrodt Hospital Products INC. | $98.25 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $95.76 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $88.41 | 2022-2023 | Tyrvaya |
| Alcon Research LLC | $35.96 | 2019 | |
| Biotissue Holdings INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Maroun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.